You have been chosen to receive this valuable information.
 
A SPECIAL
ANNOUNCEMENT FROM:
  ACT Logo  
Not rendering correctly? View this email as a web page here.
Almac Logo
Case Study: Formulating the blueprint for effective clinical labelling in ultra-low temperature conditions

Hi there,

The emergence of biologics has contributed towards impressive advancements in the treatment of multiple disease types; offering improved quality of life and better health outcomes to millions of patients worldwide. For one biotechnology company, the need to maintain ultra-low temperature conditions was a necessity, but came with many challenges. 

Download our latest case study to find out how they built an effective strategy to respond to this unique set of requirements. 
Case Study: Formulating the blueprint for effective clinical labelling in ultra-low temperature conditions


Kind regards,
Almac Clinical Services

Almac Group
Linked In Logo Linked In Logo Vimeo Logo PNG for New Guidelines.png

Please view our Privacy Policy which explains how and why we may use your personal information and the steps we take to protect it. 
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Applied Clinical Trials, a UBM publication. You are on the mailing list as %%emailaddress%%.